Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Prediabetic State

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Prediabetic State in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Prediabetic State: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, PB1
Plaza, MJ1
Kraas, J1
Burbank, N1
Elster, AW1
Garg, P1
Garg, S1
Gage, HD1
Calles-Escandon, J1
Wagner, JD1
Morton, K1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Prediabetic State

ArticleYear
Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreas.
    Diabetes technology & therapeutics, 2009, Volume: 11, Issue:2

    Topics: Animals; Fluorine Radioisotopes; Fluorobenzenes; Insulin-Secreting Cells; Mice; Pancreas; Parasympat

2009